Interleukin-6 and Tumour Necrosis Factor Alpha Synthesized by Cholesteatoma Cells Affect Mucociliary Function in the Eustachian Tube

References

• Baumann H, Gauldie J. Acute phase response. Im-munol Today 1994; 15: 74–80.
   PubMed Web of Science ®Google Scholar
• Ahn JM, Huang CC, Abramson M. Localization of interleukin-1 in human cholesteatoma. Am J Otolaryn-gol 1990; 11: 71–7.
   Google Scholar
• Schilling V, Negri B, Bujia J, et al. Possible role of interleukin-1 a and interleukin-1 p in the pathogenesis of cholesteatoma of the middle ear. Am J Otol 1992; 13: 350–5.
   PubMedGoogle Scholar
• Kim CS, Lee CH, Chung JVV, Kim CD. Interleukin-la, interleukin-1 p and interleukin-8 gene expression in hu-man aural cholesteatomas. Acta Otolaryngol (Stockh) 1996; 116: 302–306.
   PubMed Web of Science ®Google Scholar
• Boxman I, Löwick C, Aarden L, Ponec M. Modulation of IL-6 expression and IL-1 activity by keratinocyte-fibroblast interaction. J Invest Dermatol 1993; 101: 316–24.
   PubMed Web of Science ®Google Scholar
• Yoshizaki K, Nishimoto N, Matsumoto K, et al. Inter-leukin-6 and expression of its receptor on epidermal keratinocytes. Cytokines 1990; 2: 381–7.
   Google Scholar
• Oxholm A, Oxholm P, Statberg B, Bendtzen K. Im-munohistological detection of interleukin 1-like molecules and tumor necrosis factor in human epider-mis before and after UVB-irradiation in vivo. Br J Dermatol 1988; 118: 369–76.
   PubMed Web of Science ®Google Scholar
• Ophir D, Hahn T, Schattner A, Wallach D, Aveil A. Tumor necrosis factor in middle ear effusion. Arch Otolaryngol Head Neck Surg 1988; 114: 1256–8.
   PubMed Web of Science ®Google Scholar
• Yellon RF, Leonard G, Marucha P, et al. Demonstra-tion of interleukin-6 in middle ear effusions. Arch Otolaryngol Head Neck Surg 1992; 118: 745–8.
   PubMedGoogle Scholar
• Bujia J, Kim C, Ostos P, Kastenbauer E, Hilltner L. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Eur Arch Otorhinolaryngol 1996; 253: 152–7.
   Google Scholar
• Steffen M, Abboud M, Potter GK, Yung YP, Moore MAS. Human mast cells produce tumor necrosis fac-tor-alpha. Immunobiology 1987; 175: 36.
   Google Scholar
• Wong GHVV, Goeddel DV. Biological activities and production of TNF-alpha. In: Powanda MC, Oppen-heim JJ, Kluger MJ, Dinarello CA, eds. Monokines and other nonlymphocytic cytokines. New York, NY: Alan R Liss, 1988: 251–60.
   Google Scholar
• Yan SD, Huang CC. Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on kerati- nocytes in vitro. Ann Otol Rhinol Laryngol 1991; 100: 157–61.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Nakai Y, Kihara S. Ciliary activity of the middle ear lining in guinea pigs. Ann Otol Rhinol Laryngol 1985; 94: 419–23.
   PubMed Web of Science ®Google Scholar
• Lim DJ, DeMaria TF, Bakaletz LO. Functional mor-phology of the tubotympanum related to otitis media. Am J Otol 1987; 8: 385–9.
   Google Scholar
• Ohashi Y, Nakai Y. Current concept of mucociliary dysfunction in otitis media with effusion. Acta Otolar-yngol (Stockh) 1991; Suppl 486: 149–61.
   Google Scholar
• Ohashi Y, Nakai Y, Kihara S, Ikeoka H. Effects of Staphylococcus aureus on the ciliary activity of the middle ear lining. Ann Otol Rhinol Laryngol 1987; 96: 225–8.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Nakai Y, Ikeoka H, et al. Acute effects of isopropyl alcohol exposure on the middle ear mucosa. J Appl Toxicol 1987; 7: 205–12.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Nakai Y, Furuya H, et al. Mucociliary disease of the middle ear during experimental otitis media with effusion induced by bacterial endotoxin. Ann Otol Rhinol Laryngol 1989; 98: 479–84.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Nakai Y, Ohno Y, Sugiura Y, Okamoto H, Hayashi M. Influenza A modification of endotoxin-in-duced otitis media with effusion in the guinea pig. Eur Arch Otorhinolaryngol 1993; 250: 27–32.
   PubMed Web of Science ®Google Scholar
• 41st World Medical Assembly. Declaration of Helsinki: recommendations guiding physicians in biomedical re-search involving human subjects. Bull Pan Am Health Organ 1990; 24: 606–9.
   Google Scholar
• Kita M, Ohmoto Y, Hirai Y, Yamaguchi N, Imanishi J. Induction of cytokines in human peripheral blood mononuclear cells by mycoplasms. Microbiol Immunol 1992; 36: 507–16.
   Google Scholar
• Matsumori A, Shioi T, Yamada T, Matsui S, Sasayama S. Vesnarinone, a new inotropic agent, in-hibits cytokine production by stimulated human blood from patients with heart failure. Circulation 1994; 89: 955–8.
   Google Scholar
• Tanaka A, Ohashi Y, Kakinoki Y, Nakai Y. Im-munotherapy suppresses both Thl and Th2 responses by allergen stimulation, but suppression of Th2 re-sponse is a more important mechanism related to the clinical efficacy of immunotherapy for perennial aller-gic rhinitis. Scand J Immunol 1998; 48: 201–11.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Nakai Y. Functional and morphological studies on chronic sinusitis mucous membrane. 1. De-cline of ciliary action in chronic sinusitis. Acta Otolar-yngol (Stockh) 1983; Suppl 397: 3–8.
   Google Scholar
• Ohashi Y, Nakai Y. Mucociliary activities in fetal rabbits. Acta Otolaryngol (Stockh) 1984; 97: 351–8.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Nakai Y, Esaki Y, Ohno Y, Sugiura Y, Okamoto H. Influenza A virus-induced otitis media and mucociliary dysfunction in the guinea pig. Acta Otolaryngol (Stockh) 1991; Suppl 486: 135–48.
   Google Scholar
• Horii Y, Muraguchi A, Suematsu S, et al. Regulation of BSF-1/IL-6 production by human mononuclear cells: macrophage-dependent synthesis of BSF-2/IL-6 by T-cells. J Immunol 1988; 141: 1529–35.
   PubMed Web of Science ®Google Scholar
• Matsuzaki N, Saji F, Kameda T, et al. In vitro and in vivo production of interleukin-6 by fetal mononuclear cells. Clin Immunol Immunopathol 1990; 55: 305–14.
   PubMedGoogle Scholar
• Grossman RM, Krueger J, Youish D, et al. Interleukin 6 is expressed in high levels in psoriasis skin and stimulates proliferation of cultured human kerati-nocytes. Proc Natl Acad Sci USA 1989; 86: 6367–71.
   PubMed Web of Science ®Google Scholar
• Ohta Y, Katayama I, Funato T, et al. In situ expres-sion of messenger RNA of interleukin-1 and inter-leukin-6 in psoriasis: interleukin-6 involved in formation of psoriasis lesions. Arch Dermatol Res 1991; 283: 351–6.
   PubMed Web of Science ®Google Scholar
• Prens EP, Benne K, Van Damme J, et al. Interleukin-1 and interleukin-6 in psoriasis. J Invest Dermatol 1990; 95: 121S–4S.
   Google Scholar
• Bujia J, Holly A, Schiling V, Negri B, Pitzke P, Schulz P. Aberrant expression of epidermal growth factor receptor in aural cholesteatoma. Laryngoscope 1993; 103: 326–9.
   PubMed Web of Science ®Google Scholar
• Bujia J, Schiling V, Holly A, Stammberger M, Kasten-bauer E. Hyperproliferation-associated keratin expres-sion in human middle ear cholesteatoma. Acta Otolaryngol (Stockh) 1993; 113: 364–8.
   PubMed Web of Science ®Google Scholar
• Mundy GR. Role of cytokines in bone resorption. J Cell Biochem 1993; 53: 296–300.
   PubMed Web of Science ®Google Scholar
• Ishimi Y, Miyaura C, Kin CH, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990; 145: 3297–303.
   PubMed Web of Science ®Google Scholar
• Pober JS, Bevilaqua MP, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA. Two distinct monokines, interleukin 1 and tumor necrosis factor each indepen-dently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986; 136: 1680–7.
   PubMed Web of Science ®Google Scholar
• Dayer JM, Beutler B, Cerami A. Cachectin/tumor ne-crosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985; 162: 2163–8.
   Google Scholar
• Bertolini DR, Nedwin GE, Bringman TS, Smith DD, Mundy GR. Stimulation of bone resorption and inhibi-tion of bone formation in vitro by human tumor necrosis factors. Nature 1986; 319: 516–8.
   Google Scholar
• Thomson BM, Mundy GR, Chamber TJ. Tumor ne-crosis factor alpha and beta induce osteoblastic cells to stimulate osteoclastic resorption. J Immunol 1987; 138: 775–9.
   Google Scholar
• Van Damme J, Opdenakker G, Simpson RJ, et al. Identification of the human 26-kD protein interferon beta2 as a B cell hybridoma (plasmacytoma) growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 1987; 165: 914–20.
   PubMed Web of Science ®Google Scholar
• Ohashi Y, Nakai Y, Morimoto K, et al. Platelet acti-vating factor compromises epithelial defense function in the airway. J Allergy Clin Immunol 1997; 100: 520–6.
   PubMed Web of Science ®Google Scholar